Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: Results from the Swedish EIRA study

Annals of the Rheumatic Diseases

Volumn 69, Issue 10, 2010, Pages 1831-1833

  Bengtsson, Camilla ^a   Kapetanovic, Meliha C ^b   Källberg, Henrik ^a   Sverdrup, Berit ^a,e   Nordmark, Birgitta ^c   Klareskog, Lars ^c   Alfredsson, Lars ^a   Lindahl, Göran ^d   Hellström, Helena ^r   Lasarett, Falu ^r   Weitoft, Tomas ^f   Lindell, Bengt ^g   Bratt, Johan ^c   Hafström, Ingiäld ^c   Leden, Ido ^h   Löfström, Björn ⁱ   Bengtsson, Ann ^j   Skogh, Thomas ^j   Lindqvist, Elisabeth ^k   Jacobsson, Lennart ^k   Huddénius, Kjell ^l   Lindström, Christin ^m   Teleman, Annika ⁿ   Baecklund, Eva ^o   Knight, Ann ^o   Svernell, Olle ^p   Stolt, Patrik ^q   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d DANDERYD HOSPITAL   (Sweden)

^e Eskilstuna Hospital   (Sweden)

^f GÄVLE HOSPITAL   (Sweden)

^g Kalmar Hospital   (Sweden)

^h CENTRAL HOSPITAL   (Sweden)

ⁱ Katrineholm Hospital   (Sweden)

^j Linköping Hospital   (Sweden)

^k LUND UNIVERSITY HOSPITAL   (Sweden)

^l Rheumatology Clinic   (Sweden)

^m Sophiahemmet AB   (Sweden)

ⁿ Spenshult Hospital   (Sweden)

^o UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^p Vastervik Hospital   (Sweden)

^q Västerås Hospital   (Sweden)

^r Västervik Hospital ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; HLA DR ANTIGEN; INFLUENZA VACCINE; TETANUS TOXOID; TICK BORNE ENCEPHALITIS VACCINE; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; HLA DRB1 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; DISEASE COURSE; HUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SMOKING; SWEDEN; VACCINATION; ADOLESCENT; ARTHRITIS, RHEUMATOID; BLOOD; CASE CONTROL STUDY; GENETICS; GENOTYPE; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; GENOTYPE; HLA-DR ANTIGENS; HLA-DRB1 CHAINS; HUMANS; MIDDLE AGED; PEPTIDES, CYCLIC; SMOKING; SWEDEN; VACCINATION; YOUNG ADULT;

EID: 77957253426     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.129908     Document Type: Article

References (20)

1. Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008;8:124-8.
2. Vial T, Descotes J. Autoimmune diseases and vaccinations. Eur J Dermatol 2004;14:86-90.
3. Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 2001;16:309-18.
4. Sibilia J, Maillefert JF. Vaccination and rheumatoid arthritis. Ann Rheum Dis 2002;61:575-6.
5. Pope JE, Stevens A, Howson W, et al. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998;25:1687-93.
6. Vasudev M, Zacharisen MC. New-onset rheumatoid arthritis after anthrax vaccination. Ann Allergy Asthma Immunol 2006;97:110-12. (Pubitemid 44156347)
7. Harrison BJ, Thomson W, Pepper L, et al. Patients who develop inflammatory polyarthritis (IP) after immunization are clinically indistinguishable from other patients with IP. Br J Rheumatol 1997;36:366-9.
8. Geboes L, De Klerck B, Van Balen M, et al. Freund's complete adjuvant induces arthritis in mice lacking a functional interferon-gamma receptor by triggering tumor necrosis factor alpha-driven osteoclastogenesis. Arthritis Rheum 2007;56:2595-607.
9. Svelander L, Holm BC, Buchtt A, et al. Responses of the rat immune system to arthritogenic adjuvant oil. Scand J Immunol 2001;54:599-605. (Pubitemid 34131769)
10. Verstraeten T, Descamps D, David MP, et al. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 2008;26:6630-8.
11. Kallberg H, Padyukov L, Plenge RM, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007;80:867-75.
12. Karlson EW, Chang SC, Cui J, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2010;69:54-60.
13. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
14. Pedersen M, Jacobsen S, Garred P, et al. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide casecontrol study in Denmark. Arthritis Rheum 2007;56:1446-53.
15. Bengtsson C, Nordmark B, Klareskog L, et al. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005;64:1588-94. (Pubitemid 41532042)
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
18. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
19. Rönnelid J, Wick MC, Lampa J, et al. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005;64:1744-9.
20. Greenland S, Rothman KJ, Lash TL. Measures of effect and measures of association. In: Rothman KJ, Greenland S, Lash TL, eds. Modern epidemiology. 3rd edn. Philadelphia, USA: Lippincott-Raven, 2008:74-83.